Pre-existing drug shows promise in fight against Covid-19

Pre-existing drug shows promise in fight against Covid-19

PanARMENIAN.Net - Researchers, by using state-of-the-art computer simulations, have identified a pre-existing drug that could fast-track a solution to the Covid-19 pandemic, Now News reports.

The study published in the journal Science Advances, the research team from the University of Chicago in the U.S. focused on finding a weakness in the Covid-19 virus to target.

The researchers chose its main protease: Mpro- a key coronavirus enzyme that plays a central role in the virus’ life cycle.

“Mpro facilitates the virus’ ability to transcribe its RNA and replicate its genome within the host cell,” the researchers said.

Further, the researchers found that the pharmaceutical drug that shows promise as a weapon against Mpro is Ebselen.

Ebselen is a chemical compound with anti-viral, anti-inflammatory, anti-oxidative, bactericidal, and cell-protective properties.

It is used to treat multiple diseases, including bipolar disorders and hearing loss.

 Top stories
The bill, published on Monday, is designed to "eliminate the shortcomings of an unreasonably broad interpretation of the key concept of "compatriot".
The earthquake caused a temporary blackout, damaged many buildings and closed a number of rural roads.
The Prosecutor’s Office has released surveillance footage and said that one of the detainees in the case, Iveri Melashvili.
Destinations welcomed 900m fewer international tourists in January–October when compared with the same period of 2019.
Partner news